INSTEP Trial

Phase 3

Recruiting

• Conditions: Recurrent or persistent pneumothorax requiring VATS pleurodesis; Respiratory - Other respiratory disorders / diseases; Surgery - Other surgery

• Registration Number: ACTRN12605000082606
• Lead Sponsor: Gavin M Wright

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-08-05
• Last Update Posted: 10 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients with surgical indication for pleurodesis due to recurrent or persistent pneumohtorax

Exclusion Criteria

Chronic NSAID usage that cannot be stopped for more than 24 hours prior to surgery.
Renal impairment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of persistent air leak, pleural space problems or recurrent pneumothorax after VATS pleurodesis.[ 7 days]

Secondary Outcome Measures

Name	Time	Method
Total analgesic usage. [ 7 days];Drug-related complications. [ 30 days];Late recurrence of pneumothorax.[ 2 years]